Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2017 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017

IRVINE, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
March 01, 2017 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors

IRVINE, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
February 22, 2017 16:05 ET | Source: CombiMatrix Corporation

CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results

Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, significantly narrowed operating loss and record...
February 15, 2017 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017

IRVINE, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
February 08, 2017 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference

IRVINE, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
February 02, 2017 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board

IRVINE, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
January 20, 2017 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss

IRVINE, Calif., Jan. 20, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
November 29, 2016 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health

IRVINE, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
November 02, 2016 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results

Rapidly growing revenue, increasing test volume, gross margin expansion, strong cash reimbursement and prudent expense management provide clear path to profitability Conference call begins today...
October 26, 2016 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016

IRVINE, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three and nine months ended September 30, 2016 after...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right